In colorectal tumors, FAT4 was described as a novel recurrently mutated gene (prevalence of 14%) (59), and more recently, it was also implicated in the regulation of the PI3K/AKT signaling pathway, inhibiting the epithelial-to-mesenchymal transition in CRC cells (60). The gene discussed is FAT4; the disease is colorectal neoplasm.